GASTRIC/GASTROESOPHAGEAL JUNCTION CANCER

Clinical trials for GASTRIC/GASTROESOPHAGEAL JUNCTION CANCER explained in plain language.

Never miss a new study

Get alerted when new GASTRIC/GASTROESOPHAGEAL JUNCTION CANCER trials appear

Sign up with your email to follow new studies for GASTRIC/GASTROESOPHAGEAL JUNCTION CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope drug enters first human tests for tough cancers

Disease control Recruiting now

This is the first human study of an experimental drug called OCT-598 for people with advanced solid tumors that have stopped responding to standard treatments. Researchers will test increasing doses to find the safest and most effective amount, both when given alone and when comb…

Matched conditions: GASTRIC/GASTROESOPHAGEAL JUNCTION CANCER

Phase: PHASE1 • Sponsor: Oscotec Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

GASTRIC/GASTROESOPHAGEAL JUNCTION CANCER

Get alerted when new GASTRIC/GASTROESOPHAGEAL JUNCTION CANCER trials appear

New hope drug enters first human tests for tough cancers